- Differential efficacy of dengue vaccine by immune status.
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Ferguson N, Burke DS, Cummings DA.
Lancet, 2015; 385: 1726.
doi: 10.1016/S0140-6736(15)60889-3
- Potential opportunities and perils of imperfect dengue vaccines.
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.
Vaccine, 2014; 32: 514-20.
doi: 10.1016/j.vaccine.2013.11.020
- Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.
Mier-y-Teran-Romero L, Schwartz IB, Cummings DA.
J Theor Biol, 2013; 332: 203-10.
doi: 10.1016/j.jtbi.2013.04.036
- Challenges in the interpretation of dengue vaccine trial results.
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Burke DS, Cummings DA.
PLoS Negl Trop Dis, 2013; 7: e2126.
doi: 10.1371/journal.pntd.0002126
